Synthetic peptides were used to validate predicted epitopes as target of T cell recognition (manuscript in preparation). Plasma samples from 253 naturally exposed individuals were tested against this chimeric protein named PvRMC-RBP1 and a control protein that includes the native sequence PvRBP123-751 in comparative experiments to study the rate of recurrence of total IgG and […]